Skip to content

A Clinical Study to know the efficacy of two different Ayurveda treatment Protocols in Adenomyosis

A Randomized Comparative Clinical trial to evaluate the efficacy of two different Ayurveda treatment protocols in Vataja yonivyapad with special reference to Adenomyosis - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085313
Enrollment
40
Registered
2025-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N800- Endometriosis of uterus

Interventions

None listed

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women of age group between 21-45 yrs Patients having complaints of either Menorrhagia Dysmenorrhea Dyspareunia Metrorrhagia and any of the Lakshanas of Vataja Vyonivyapad (Yoni Toda Vedana Sthamba Pipeelika Srupti Karkashata Supthi Aayasa and Sa Shabdha Ruk Phena Tanu Ruksha Aartava) Diagnosis of adenomyosis confirmed by USG Patients who are fit for both Matra Basti and Virechana karma

Exclusion criteria

Exclusion criteria: Known case of Diabetes Mellitus Hypertension Thyroid disorder and severe anaemia less than 7 gm per dl Patients with congenital anomaly of reproductive tract Known case of Malignancy of any part of the body Known case of Pelvic inflammatory disease Positive caes of HIV VDRL HBsAG HCV Patients using oral contraceptive pills and intra uterine contraceptive devices Patients unfit for both Matra basti and virechana

Design outcomes

Primary

MeasureTime frame
Changes in the clinical features (Interval between two menstrual cycle Duration of menstrual bleeding Quantity of menstrual bleeding Pain during menses Dyspareunia Lakshanas of Vataja Vyonivyapad YoniToda Vedana Sthamba Pipeelika Srupti Karkashata Supthi Aayasa and Sa Shabdha Ruk Phena Tanu Ruksha Aartava and assess adenomyotic changes in uterus on USGTimepoint: 90 days

Secondary

MeasureTime frame
Changes in quality of lifeTimepoint: 90 days

Countries

India

Contacts

Public ContactDr Sindhu K A

National Institute of Ayurveda

baruhunt@gmail.com9799997940

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026